BAYZED HEALTH released its interim results, with a loss attributable to shareholders of 27.62 million yuan, an increase of 139.18% year-on-year

智通財經
2025.08.26 14:37

智通財經 APP 訊，佰澤醫療發佈截至 2025 年 6 月 30 日止六個月的中期業績，收入 5.75 億元 (人民幣，下同)，同比增加 0.66%;股東應占虧損 2762 萬元，同比擴大 139.18%;每股基本虧損 0.02 元。

智通財經 APP 訊，佰澤醫療 (02609) 發佈截至 2025 年 6 月 30 日止六個月的中期業績，收入 5.75 億元 (人民幣，下同)，同比增加 0.66%;股東應占虧損 2762 萬元，同比擴大 139.18%;每股基本虧損 0.02 元。

Source: 智通財經 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.